Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Granito

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Digestive Diseases and Sciences|December 13, 2006
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis CPaolo Muratori, Albert J Czaja, Luigi Muratori, et al.
Frontiers in Neurology|May 9, 2025
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case seriesLorenzo Muccioli, Lidia Di Vito, Elena Pasini, et al.
Journal of Personalized Medicine|October 23, 2021
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular CarcinomaAlessandro Granito, Antonio Facciorusso, Rodolfo Sacco, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitisSilvia Ferri, Maria Serena Longhi, Chiara De Molo, et al.
Magnetic Resonance Imaging|September 14, 2020
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liverMatteo Renzulli, Stefano Brocchi, Anna Maria Ierardi, et al.
Clinical and Translational Gastroenterology|January 14, 2021
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Future Oncology (London, England)|August 10, 2018
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life studyRodolfo Sacco, Alessandro Granito, Irene Bargellini, et al.
Clinical and Translational Gastroenterology|April 27, 2021
Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Cancers|March 28, 2024
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with SorafenibMaurizio Biselli, Nicola Reggidori, Massimo Iavarone, et al.
Cancers|November 3, 2020
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic RoleStefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Digestive Diseases and Sciences|December 13, 2006
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis CPaolo Muratori, Albert J Czaja, Luigi Muratori, et al.
Frontiers in Neurology|May 9, 2025
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case seriesLorenzo Muccioli, Lidia Di Vito, Elena Pasini, et al.
Journal of Personalized Medicine|October 23, 2021
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular CarcinomaAlessandro Granito, Antonio Facciorusso, Rodolfo Sacco, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitisSilvia Ferri, Maria Serena Longhi, Chiara De Molo, et al.
Magnetic Resonance Imaging|September 14, 2020
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liverMatteo Renzulli, Stefano Brocchi, Anna Maria Ierardi, et al.
Clinical and Translational Gastroenterology|January 14, 2021
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Future Oncology (London, England)|August 10, 2018
Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life studyRodolfo Sacco, Alessandro Granito, Irene Bargellini, et al.
Clinical and Translational Gastroenterology|April 27, 2021
Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Cancers|March 28, 2024
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with SorafenibMaurizio Biselli, Nicola Reggidori, Massimo Iavarone, et al.
Cancers|November 3, 2020
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic RoleStefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, et al.
Pageof 14